This inventor holds 1 USPTO granted patent. Top assignee: Columbia University. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Kausik Si: Innovator in Prion Research
Introduction
Kausik Si is a notable inventor based in Kansas City, MO (US). He has made significant contributions to the field of molecular biology, particularly in understanding prion-like proteins. His work has implications for various biological processes and potential therapeutic applications.
Latest Patents
Kausik Si holds a patent for a "Prion-like form of CPEB and related compositions and methods." This invention provides methods for determining whether an agent facilitates the conversion of a cytoplasmic polyadenylation element binding (CPEB) protein from its non-prion form to its prion form. It also includes methods for determining the presence and amount of the prion form of CPEB protein in a cell. Furthermore, the invention outlines methods for facilitating the conversion of a non-prion CPEB protein to its prion form. It also provides an isolated prion form of CPEB protein and compositions comprising a therapeutically effective amount of an agent that facilitates this conversion, along with methods of making such compositions. Kausik Si has 1 patent to his name.
Career Highlights
Kausik Si is affiliated with Columbia University, where he conducts research and contributes to advancements in his field. His work is recognized for its innovative approach to understanding protein behavior and its potential applications in medicine.
Collaborations
Kausik Si collaborates with Eric R Kandel, a prominent figure in neuroscience. Their partnership enhances the research output and fosters a deeper understanding of the mechanisms underlying prion-like proteins.
Conclusion
Kausik Si's contributions to the field of prion research highlight the importance of innovation in understanding complex biological processes. His work not only advances scientific knowledge but also opens avenues for potential therapeutic interventions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
